{"id":"https://openalex.org/W2120380960","doi":"https://doi.org/10.1158/1078-0432.ccr-09-0343","title":"Targeting NEDD8-Activated Cullin-RING Ligases for the Treatment of Cancer","display_name":"Targeting NEDD8-Activated Cullin-RING Ligases for the Treatment of Cancer","alternate_titles":[],"publication_year":2009,"publication_date":"2009-06-15","ids":{"openalex":"https://openalex.org/W2120380960","doi":"https://doi.org/10.1158/1078-0432.ccr-09-0343","mag":"2120380960","pmid":"https://pubmed.ncbi.nlm.nih.gov/19509147"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-09-0343","doi":"https://doi.org/10.1158/1078-0432.ccr-09-0343","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-09-0343","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2120380960"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063604217","display_name":"Teresa A. Soucy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Teresa A. Soucy","raw_affiliation_strings":["Authors' Affiliations: Discovery, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts","Discovery, Millennium Pharmaceuticals, Inc, Cambridge, Massachusetts 02139, USA. teresa.soucy@mpi.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Discovery, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4405270001"]},{"raw_affiliation_string":"Discovery, Millennium Pharmaceuticals, Inc, Cambridge, Massachusetts 02139, USA. teresa.soucy@mpi.com","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091086352","display_name":"Peter G. Smith","orcid":"https://orcid.org/0000-0002-1931-7660","observed_orcids":["https://orcid.org/0000-0002-1931-7660"]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter G. Smith","raw_affiliation_strings":["Authors' Affiliations: Discovery, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Discovery, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059110616","display_name":"Mark Rolfe","orcid":"https://orcid.org/0009-0001-7585-2684","observed_orcids":["https://orcid.org/0009-0001-7585-2684"]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark Rolfe","raw_affiliation_strings":["Authors' Affiliations: Discovery, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Discovery, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4405270001"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405270001"],"apc_list":null,"apc_paid":null,"fwci":4.4991,"has_fulltext":false,"cited_by_count":237,"citation_normalized_percentile":{"value":0.96212415,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"15","issue":"12","first_page":"3912","last_page":"3916"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nedd8-activating-enzyme","display_name":"NEDD8-activating enzyme","score":0.8619999885559082},{"id":"https://openalex.org/keywords/cullin-ring-ubiquitin-ligases","display_name":"cullin-RING ubiquitin ligases","score":0.902999997138977},{"id":"https://openalex.org/keywords/e3-ubiquitin-ligase","display_name":"E3 ubiquitin ligase","score":0.9470000267028809},{"id":"https://openalex.org/keywords/ubiquitin-proteasome-system","display_name":"ubiquitin-proteasome system","score":0.8460000157356262},{"id":"https://openalex.org/keywords/protein-degradation","display_name":"protein degradation","score":0.5860000252723694},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.6510000228881836},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.8489999771118164},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.9890000224113464}],"concepts":[{"id":"https://openalex.org/C2779231659","wikidata":"https://www.wikidata.org/wiki/Q6953444","display_name":"NEDD8","level":5,"score":0.9444869756698608},{"id":"https://openalex.org/C2778567606","wikidata":"https://www.wikidata.org/wiki/Q41797435","display_name":"Cullin","level":5,"score":0.8722116947174072},{"id":"https://openalex.org/C25602115","wikidata":"https://www.wikidata.org/wiki/Q407111","display_name":"Ubiquitin","level":3,"score":0.7954040169715881},{"id":"https://openalex.org/C45005369","wikidata":"https://www.wikidata.org/wiki/Q21115705","display_name":"Neddylation","level":5,"score":0.7894525527954102},{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.6241469979286194},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5108909010887146},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.49957895278930664},{"id":"https://openalex.org/C2908868211","wikidata":"https://www.wikidata.org/wiki/Q4274835","display_name":"Ubiquitin-Protein Ligases","level":5,"score":0.49660784006118774},{"id":"https://openalex.org/C134459356","wikidata":"https://www.wikidata.org/wiki/Q4274835","display_name":"Ubiquitin ligase","level":4,"score":0.47984644770622253},{"id":"https://openalex.org/C2992195973","wikidata":"https://www.wikidata.org/wiki/Q33123","display_name":"Protein degradation","level":2,"score":0.4492654502391815},{"id":"https://openalex.org/C182561583","wikidata":"https://www.wikidata.org/wiki/Q7876535","display_name":"Ubiquitin-conjugating enzyme","level":5,"score":0.4300440549850464},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.41205090284347534},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3810693025588989},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3792050778865814},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3492661118507385},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.061507463455200195},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000075687","descriptor_name":"NEDD8 Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001897","descriptor_name":"Boronic Acids","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001897","descriptor_name":"Boronic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003517","descriptor_name":"Cyclopentanes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014452","descriptor_name":"Ubiquitins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016328","descriptor_name":"NF-kappa B","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D044763","descriptor_name":"Ubiquitin-Conjugating Enzymes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D044764","descriptor_name":"Ubiquitin-Activating Enzymes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D044767","descriptor_name":"Ubiquitin-Protein Ligases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D044842","descriptor_name":"Cullin Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D046988","descriptor_name":"Proteasome Endopeptidase Complex","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D054829","descriptor_name":"RING Finger Domains","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D061988","descriptor_name":"Proteasome Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-09-0343","doi":"https://doi.org/10.1158/1078-0432.ccr-09-0343","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-09-0343","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:19509147","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19509147","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W1539814399","https://openalex.org/W1603251764","https://openalex.org/W1769736739","https://openalex.org/W1958512987","https://openalex.org/W1964021682","https://openalex.org/W1964492562","https://openalex.org/W1971238944","https://openalex.org/W1978878131","https://openalex.org/W1988031203","https://openalex.org/W1989088998","https://openalex.org/W1991000990","https://openalex.org/W1991105254","https://openalex.org/W1994755995","https://openalex.org/W1996632098","https://openalex.org/W2005750837","https://openalex.org/W2007613155","https://openalex.org/W2012032483","https://openalex.org/W2012968622","https://openalex.org/W2013108773","https://openalex.org/W2015866661","https://openalex.org/W2020738975","https://openalex.org/W2023100224","https://openalex.org/W2025861321","https://openalex.org/W2032590709","https://openalex.org/W2044724807","https://openalex.org/W2044883494","https://openalex.org/W2055878807","https://openalex.org/W2066635148","https://openalex.org/W2068784898","https://openalex.org/W2073709571","https://openalex.org/W2073996456","https://openalex.org/W2076194625","https://openalex.org/W2094920743","https://openalex.org/W2097933346","https://openalex.org/W2108235071","https://openalex.org/W2112052713","https://openalex.org/W2120772426","https://openalex.org/W2121077625","https://openalex.org/W2122674109","https://openalex.org/W2123077018","https://openalex.org/W2126267349","https://openalex.org/W2126344344","https://openalex.org/W2136128861","https://openalex.org/W2138779676","https://openalex.org/W2138822307","https://openalex.org/W2140219059","https://openalex.org/W2147246240","https://openalex.org/W2148561037","https://openalex.org/W2154602568","https://openalex.org/W2155324869","https://openalex.org/W2158957674","https://openalex.org/W2166761147","https://openalex.org/W2166987747"],"related_works":["https://openalex.org/W2147045066","https://openalex.org/W2076194625","https://openalex.org/W2069777002","https://openalex.org/W1985593766","https://openalex.org/W3009572700","https://openalex.org/W2473278872","https://openalex.org/W2327334027","https://openalex.org/W4256641779","https://openalex.org/W4220767977","https://openalex.org/W2007725104"],"abstract_inverted_index":{"E3":[0,94],"ubiquitin":[1,57,93],"ligases":[2,95],"regulate":[3],"many":[4],"dynamic":[5],"cellular":[6,81],"processes":[7],"important":[8],"for":[9,38,60,120,176],"cancer":[10],"cell":[11],"survival.":[12],"Together":[13],"with":[14,163],"ubiquitin-activating":[15],"enzyme":[16,126],"(E1)":[17],"and":[18,83,136,158,180],"ubiquitin-conjugating":[19],"enzymes":[20],"(E2s),":[21],"E3s":[22,65],"catalyze":[23],"the":[24,35,44,50,56,72,77,98,113,129,133,140,149,152,160],"ubiquitination":[25],"of":[26,43,52,55,79,101,142,151],"numerous":[27],"protein":[28,115],"substrates":[29],"that":[30,105,168],"are":[31],"subsequently":[32],"targeted":[33],"to":[34,74],"26S":[36],"proteasome":[37,45,58],"degradation.":[39],"The":[40,91,103],"clinical":[41,174,192],"success":[42],"inhibitor":[46,167],"bortezomib":[47],"has":[48],"encouraged":[49],"evaluation":[51],"other":[53,89],"components":[54],"system":[59],"pharmaceutical":[61],"intervention.":[62],"Targeting":[63],"specific":[64],"is":[66,71,169],"particularly":[67],"attractive":[68],"because":[69],"there":[70],"potential":[73],"selectively":[75],"block":[76],"degradation":[78],"certain":[80],"proteins":[82],"possibly":[84],"avoid":[85],"unwanted":[86],"effects":[87],"on":[88,112],"proteins.":[90],"cullin-RING":[92],"(CRLs)":[96],"represent":[97],"largest":[99],"subfamily":[100],"E3s.":[102],"requirement":[104],"CRLs":[106,157],"be":[107],"activated":[108],"by":[109],"NEDD8":[110,134,153],"modification":[111],"cullin":[114],"offers":[116],"an":[117],"\"achilles":[118],"heel\"":[119],"modulating":[121],"this":[122,145],"entire":[123],"subfamily.":[124],"NEDD8-activating":[125],"(NAE)":[127],"catalyzes":[128],"first":[130],"step":[131],"in":[132,155,171],"pathway":[135,154],"as":[137],"such":[138],"controls":[139],"activity":[141],"CRLs.":[143],"In":[144,183],"article,":[146],"we":[147,185],"describe":[148],"role":[150],"activating":[156],"discuss":[159],"preclinical":[161],"findings":[162],"a":[164],"first-in-class":[165],"NAE":[166,188],"currently":[170],"phase":[172],"I":[173],"trials":[175],"both":[177],"solid":[178],"tumor":[179],"hematological":[181],"malignancies.":[182],"addition,":[184],"speculate":[186],"where":[187],"inhibitors":[189],"may":[190],"find":[191],"utility.":[193]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2120380960","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":22},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":18},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":18},{"year":2013,"cited_by_count":20},{"year":2012,"cited_by_count":17}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
